

Most Read This Week
- Tumor Genomic and Gut Microbiota Association With Clinical Outcomes in Newly Diagnosed Glioblastoma Treated With Atezolizumab, Temozolomide, and Radiation
- Updated Results of Belzutifan for Advanced RCC
- Omitting Radiotherapy After Breast-Conserving Surgery in Low-Grade Luminal A Breast Cancer
- Proton Craniospinal Irradiation With Photon Involved-Field Radiotherapy for Solid Tumor Leptomeningeal Metastasis
- ASCO Guideline Update for Systemic Therapy for HER2+ Advanced Breast Cancer
Recently Updated
- Overall Survival With First-Line Palbociclib Plus Letrozole vs Placebo Plus Letrozole in Women With ER+/HER2− Advanced Breast Cancer
- Association of Major Adverse Cardiac Events With Immune Checkpoint Inhibitors
- Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma
- Hormone Therapy-Related Hot Flashes Tied to Worse Breast Cancer Outcomes
- Pembrolizumab Plus Axitinib vs Sunitinib as First-Line Therapy for Advanced ccRCC